Sigfridsson K - Search Results

1

Probing adsorption of DSPE-PEG2000 and DSPE-PEG5000 to the surface of felodipine and griseofulvin nanocrystals.

Rydberg HA, Yanez Arteta M, Berg S, Lindfors L, Sigfridsson K. Rydberg HA, et al. Among authors: sigfridsson k. Int J Pharm. 2016 Aug 20;510(1):232-9. doi: 10.1016/j.ijpharm.2016.06.046. Epub 2016 Jun 18. Int J Pharm. 2016. PMID: 27329674

2

Evaluation of preclinical formulations for a poorly water-soluble compound.

Granath AK, Sigfridsson K. Granath AK, et al. Among authors: sigfridsson k. Int J Pharm. 2016 Sep 10;511(1):630-637. doi: 10.1016/j.ijpharm.2016.07.041. Epub 2016 Jul 25. Int J Pharm. 2016. PMID: 27462026

3

Biopharmaceutic Profiling of Salts to Improve Absorption of Poorly Soluble Basic Drugs.

Tannergren C, Karlsson E, Sigfridsson K, Lindfors L, Ku A, Polentarutti B, Carlert S. Tannergren C, et al. Among authors: sigfridsson k. J Pharm Sci. 2016 Nov;105(11):3314-3323. doi: 10.1016/j.xphs.2016.07.016. Epub 2016 Sep 13. J Pharm Sci. 2016. PMID: 27637320 Clinical Trial.

4

Nanocrystal formulations of a poorly soluble drug. 1. In vitro characterization of stability, stabilizer adsorption and uptake in liver cells.

Sigfridsson K, Skantze U, Skantze P, Johansson S, Grant I, Smedsrød B, Fuglesteg B, Elvevold K, Lindfors L. Sigfridsson K, et al. Int J Pharm. 2017 Feb 25;518(1-2):29-40. doi: 10.1016/j.ijpharm.2016.12.035. Epub 2016 Dec 21. Int J Pharm. 2017. PMID: 28012994

5

Nanocrystal formulations of a poorly soluble drug. 2. Evaluation of nanocrystal liver uptake and distribution after intravenous administration to mice.

Sigfridsson K, Skantze P, Skantze U, Svensson L, Löfgren L, Nordell P, Michaëlsson E, Smedsrød B, Fuglesteg B, Elvevold K, Lindfors L. Sigfridsson K, et al. Int J Pharm. 2017 May 30;524(1-2):248-256. doi: 10.1016/j.ijpharm.2017.03.062. Epub 2017 Mar 31. Int J Pharm. 2017. PMID: 28373104

6

Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulation.

Cao E, Lindgren A, Martinsson S, Hu L, Lindfors L, Sigfridsson K, Skantze U, Michaëlsson E, Trevaskis NL, Porter CJH. Cao E, et al. Among authors: sigfridsson k. J Control Release. 2019 Feb 28;296:29-39. doi: 10.1016/j.jconrel.2019.01.002. Epub 2019 Jan 3. J Control Release. 2019. PMID: 30611901

7

Sustained release and improved bioavailability in mice after subcutaneous administration of griseofulvin as nano- and microcrystals.

Sigfridsson K, Xue A, Goodwin K, Fretland AJ, Arvidsson T. Sigfridsson K, et al. Int J Pharm. 2019 Jul 20;566:565-572. doi: 10.1016/j.ijpharm.2019.06.015. Epub 2019 Jun 7. Int J Pharm. 2019. PMID: 31181305

8

Nano- and microcrystals of griseofulvin subcutaneously administered to rats resulted in improved bioavailability and sustained release.

Sigfridsson K, Rydberg H, Strimfors M. Sigfridsson K, et al. Drug Dev Ind Pharm. 2019 Sep;45(9):1477-1486. doi: 10.1080/03639045.2019.1628769. Epub 2019 Jul 1. Drug Dev Ind Pharm. 2019. PMID: 31260340

9

A candidate drug administered subcutaneously to rodents as drug particles showing hepatic recirculation which influenced the sustained release process.

Sigfridsson K, Arvidsson T, Xue A, Wagner DJ, Pop-Damkov P, Zhang G, Strimfors M. Sigfridsson K, et al. Int J Pharm. 2020 May 15;581:119252. doi: 10.1016/j.ijpharm.2020.119252. Epub 2020 Mar 30. Int J Pharm. 2020. PMID: 32240808

10

Supersaturated formulations of poorly soluble weak acid drugs evaluated in rodents; a case study.

Sigfridsson K, Andreasson T, Fihn BM, Kearns M, Lindblom S. Sigfridsson K, et al. Int J Pharm. 2021 Sep 5;606:120883. doi: 10.1016/j.ijpharm.2021.120883. Epub 2021 Jul 13. Int J Pharm. 2021. PMID: 34271156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters